outcome is chosen. Clinically, in some cases, a shunt can be helpful, but a methodical approach to standardize decision-making is lacking.
Common physical characteristics are presentation within the first 6 months of life, a large dome-shaped head, open fontanelles or larger calvarial defects, and bilateral ventrolateral strabismus. Clinical signs usually reflect a forebrain disorder and include obtundation, behavior abnormalities, difficulty in house training, decreased vision or blindness, circling, pacing, restlessness, and seizure activity. Affected dogs predominantly present with enlarged lateral as well as third ventricles, although distension of the 4th ventricle also has been described. 3 The purpose of ventriculoperitoneal shunt (VPS) surgery is to allow CSF flow through a shunting mechanism from the intracranial ventricles to the peritoneum. Although surgery is the treatment of choice when treating hydrocephalus, complications are relatively common. In humans, causes for shunt failure include mechanical failure of the shunt, infection, and functional failure from overshunting or undershunting.
Attention was focused on the identity of the complications and the time frame within which they arose. The applied shunt systems were assessed for complications. The hypotheses were the main complication when placing a VPS in dogs and cats is shunt occlusion, and there are no differences in the kind of complications between dogs and cats.
| MATERIALS AND METHODS
For this systematic review, the "RCVS Knowledge" and the published standard for reporting systematic reviews following the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines" were used as a guideline for evidence-based medicine. 4, 5 By "The PICO Method" (P- including when only the abstract was written in English. 6 Further inclusion criteria were feline and canine patients with idiopathic hydrocephalus, congenital hydrocephalus, external hydrocephalus, treatment by VPS, case reports and case series, clear outcome of complications, and timeline. A search in the databases resulted in 752 articles ( Figure 1 ). In 1 study, outcomes of idiopathic and acquired hydrocephalus were evaluated as a single disease, and thus the study had to be excluded. The corresponding author could not be reached for comment. 7 Ultimately, 16 papers were included in the literature review and classified in "Levels of Evidence for Prognostic Studies". Case reports were assigned to Level V (expert opinion, case report, or clinical example) and case series to Level IV. 8 Among these were 3 case series and 13 case reports. As a case number, 60 dogs were included, 50 from case series and 10 from case reports. Thirteen cats were eligible, 7 were part of case series and 6 were case reports. and to determine if a significant difference in complications evolves in dogs and cats, these species are described separately. In 2 dogs and 2 cats, the shunt type and valve were not specified, leaving 57 dogs and 11 cats for statistical analysis.
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| Statistics
To determine if any significant differences occurred in complications between dogs and cats, the confidence interval (CI) was used in statistical analysis. The CI is the range of values in which the true value in the population is expected to fall, based on the study results. The probability that the true value lies outside the CI was given <5%. 14 To assess significant differences in complications between dogs and cats, the level of confidence of 95% was assumed. To assess the complication rate of different shunt systems, the CI of 95% also was applied.
3 | RESULTS
| Case series
From the case series, 50 dogs and 7 cats could be analyzed ( Table 1 ).
The cats had no shunt-related complications described. . 17 A summary of the complications described in case series can be found in Table 1 .
| Case reports
Six cats and 10 dogs with VPS shunt placement were reported in 14 case reports. In cats, coiling (2/6; 33.3%) in combination with migration of the peritoneal catheter was described as the most common complication. 6, 18 Other complications were obstruction (1/6; 16.7%) and subdural hematoma in combination with kinking of the distal catheter (1/6; 16.7%). 6, 19 Two cats had preoperative and postoperative seizures. 11 The median follow-up time in cats was 27.8 months (range, 13-42 months). All cats were alive at the time of writing (Table 2 ).
In dogs described in case reports, the complications were disconnections (1/10; 10%), 20 obstruction (1/10; 10%), 21 overshunting with slit-like ventricle (1/10; 10%), 20 and postoperative seizures in combination with breakage of the tube (1/10; 10%). 22 Subdural fluid on postoperative magnetic resonance imaging (MRI) (2/10; 20%) was not clinically relevant. 23 Two dogs had preoperative as well as postoperative seizures. 22, 24 Three dogs with preoperative seizures had no further seizure activity after VPS placement. 12, 25, 26 Median follow-up time was 11 months (range, 2-42 months) with 2 nonsurvivors (Table 3) .
One dog died as a consequence of seizures 32 months after the 1st surgery; 1 dog was euthanized because of overshunting after 2 surgeries 5 months after the initial surgery. 20, 22 To summarize, the complications described in case reports were coiling (n = 2), obstruction (n = 1), kinking (n = 1), disconnection (n = 1), overshunting (n = 1), and breakage of the tube (n = 1). The complications of case series and case reports are summarized in Table 4 . The complications were related to the time after surgery. Twenty-one of 26 complications occurred within the first 6 months.
| Overall complications
Obstruction was the most common complication (7/73; 9.6%). In 1 dog, an ependymal vessel was punctured during placement of the VPS, which led to shunt obstruction. The dog was euthanized within a short period of time. 17 One dog was successfully treated for shunt occlusion using prednisolone, amoxicillin, 0.9% NaCl fluids, buprenorphine, and omeprazole during the short term. 21 Two dogs were euthanized mid-term and 1 was euthanized long-term because of shunt occlusion. Two of those dogs had infection identified as an underlying cause. One dog developed shunt occlusion mid-term and underwent successful revision surgery. 15 One cat had a diagnosis of shunt obstruction, but lack of clinical signs precluded further treatment. 6 Three dogs (3/73; 4.1%) with shunt infection were described in 1 case series. 15 In 2 cases, this resulted in occlusion of the shunt and the owners chose euthanasia (1 in the short-term and 1 in the mid-term).
The causative agents could not be identified. One patient had successful revision surgery in the long-term period. 15 The dog underwent successful shunt replacement 21 months after the first surgical intervention. No bacteria were cultured from a CSF sample, but the diagnosis was made on the basis of neutrophilic pleocytosis with karyolysis.
Overshunting was found in 2 dogs (2/73; 2.7%). One dog died acutely in the short-term, 2 weeks after surgery, because of overshunting and brain collapse. 15 The second dog developed overshunting within the mid-term period and was treated by a slow injection of saline solution and disconnection of the shunt. Neurological signs did Kinking of the peritoneal catheter with insufficient drainage was described in 2 (2/73; 2.7%) patients. In the dogs, the time of onset was 4 months after surgery. 16 Kinking of the catheter occurred in 1 cat in the short-term period. In both cases, revision surgery resulted in sustained clinical improvement. 19 Coiling of the peritoneal catheter in the SC tissue occurred in 2 cats (2/73; 2.7%). The first cat had revision surgery 13 weeks after implantation with a follow-up time of 26 months. 18 The second cat with SC coiling showed no neurological signs after a follow-up time of 17 months. 9 complications occurred within the first 3 months, 12 complications between 3 and 6 months, and 3 occurred after 6 months. In 2 complications, the time of onset was not described. Nine dogs and 2 cats were lost to follow-up (11/73; 15%). 
| CI for the complications and valves used
| DISCUSSION
Shunt catheter obstruction was by far the most common cause for shunt malfunction. Obstructions may occur within every part of the shunting system. Obstruction of the proximal catheter occurred in 9.6% of the patients and kinking of the distal catheter in 2.7%. The most common site of obstruction was the proximal catheter, which is comparable to studies of humans. 28 One study evaluated long-term follow-up shunting therapy and determined that obstruction was responsible for 56% of shunt failures in children. 29 One speculation is that the proximal catheter may become obstructed by brain parenchyma as it is passed through the cerebral cortex. However, protecting the proximal catheter with a removable sheath has not improved revision rates. 30 
| Infection
In human patients with clinical signs of shunt malfunction, infection should always be suspected. Infection is the second most common cause of malfunction with a reported rate of approximately 8%-15%
among patients who undergo VPS placement. 32 In our study, 2 of the 3 described dogs subsequently developed an obstruction. In both cases, bacterial cultures were positive. In the third dog, a CSF sample had neutrophilic pleocytosis with evident karyolysis, but bacterial culture was negative. In pediatric surgery, infection rates after VPS placement are 5%-20%. 28 The infecting agent is most likely inoculated at the time of surgery, with staphylococci most commonly isolated. 29 As a result, infection develops a short time after surgery in children, with most infections progressing within 2 months after shunt insertion.
These findings do not fully correlate with our results because the dogs developed infection at 2, 13, and 21 months after shunt implantation.
It can be challenging to distinguish primary obstruction from infectiousrelated obstructions because the clinical signs of primary obstructions are nausea, vomiting, headache, and fever. One study found that the presence of fever and >10% neutrophils ventricular fluid had a specificity of 99%, a positive predictive value of 93%, and a positive test probability of 92% for predicting shunt infection. 33 In the human medical literature, risk factors for shunt infection have been identified: young age, postoperative CSF leakage, glove holes during shunt handling, African American race, public insurance, previous shunt infections, and intraventricular hemorrhage. 34 To prevent shunt infection in humans, risk reduction is achieved by restriction of operating room personnel, effective asepsis, VPS surgery early in the morning, as well as minimal skin exposure, double gloving, and prophylactic administration of antimicrobials. 29 Antibiotic-impregnated shunt systems seem to be a viable option to prevent infection in human medicine. The impregnated shunt systems provided anti-staphylococcal protection, particularly during the early postoperative period, which is prone to shunt infections. 35 Another approach to decrease the infection risk in pediatric patients is to inject vancomycin and gentamicin in the reservoir of the shunt and around the peritoneal catheter once or twice. 36 The usage of antibiotic-impregnated shunt systems in veterinary medicine has yet to be described. However, the difference in time of onset of infection between animals and children may play a role in the effectiveness of the impregnated shunts.
| Overshunting
Overshunting with neurological deterioration and slit-like ventricles was found in 2 patients. In 3 animals with VPS placement, baseline MRI identified a subdural hematoma. The animals showed no clinical signs, and overshunting was reported as an incidental finding during baseline MRI with no further consequences. In human medicine, subdural hematomas after shunt placement have been described in up to 53% of patients with normal pressure hydrocephalus. Some subdural hematomas do not cause clinical signs and can resolve spontaneously, but in approximately 16%, the subdural collections require surgical intervention. 37 It is thought that bridging veins are stretched as the brain sinks away from the skull when the pressure inside the ventricles decreases after shunting. 34 Programmable shunt valves, in which the opening pressure of the valve can be changed postoperatively, seem to work efficiently. Cases have been reported in which adjustment of the shunt valve alone has allowed for complete resolution of subdural hematomas. 38 The costs of these valves may limit their use in veterinary medicine. In order to prevent this phenomenon, lowpressure or very-low-pressure valves are used most frequently in animals. In 2 described cases in our review, a paediGAV system was used.
The opening pressure (ie, if it was 4/14 or 4/24) was not described in 1 case series. 15 In the described case report, a 4/24 valve was used and sutured to the long axis of the dog in a horizontal direction. valveless and valve systems, but because of our overall low case number, no conclusion can be drawn about these findings. or between the valve and the distal catheter. In the 3 described cases, the disconnection occurred between the valve and the distal catheter (n = 2) and between the anchor and the abdominal catheter (n = 1). 15, 17 Two underwent successful revision surgery and 1 was euthanized because of shunt disconnection. In that dog, it was suspected that tension occurred because of SC adhesion of the tube in the neck area. 20 Eight percent (25/305; 8.1%) of revision surgeries in a published study of children were performed because of disconnection of the catheters.
The most common location for disconnection was in the cervical region in 12 patients and the distal valve junction in 6 patients. 39 In humans, the most common complications are associated with undershunting:
headaches, vomiting, and drowsiness. These clinical signs are not described in veterinary medicine. Except for vomiting, these signs are subjective and may be overlooked by pet owners. Veterinary patients do not necessarily show any clinical signs after disconnection of the shunting system, and routing postoperative imaging studies should be recommended. In human medicine, disconnection occurs as a consequence of scar formation along the catheter in the mobile cervical region. Uni-shunts may prevent disconnection, but no parts of the shunt system can be changed in cases of kinking or obstruction. 39 To allow free movement of the head and to address growth of the animal, some surgeons place loops of the catheter on the neck. Two catheters kinked and became ineffective: In 1 dog a loop led to kinking of the catheter in the neck or cranial vault area. 16 In the second case, the abdominal portion of the catheter in a cat kinked, but the exact location was not described. Thus, it is unclear if the kinking appeared at the entry point into the abdomen, in the abdomen, or along the SC pathway. 19 Revision surgery resulted in sustained clinical improvement.
Coiling of the abdominal catheter occurred in 2 cats, a complication that was not observed in dogs. The incidence of retrograde migration of the peritoneal catheter in human medicine is as high as 0.6% and occurs in the first 3 months after surgery. 40 In our review, 1 cat had revision surgery at 13 weeks after surgery, in the other cat coiling was an incidental finding with no clinical signs. 6, 18 Revision surgery and replacement of the peritoneal catheter within a new SC tunnel was successfully performed. This approach also is the current treatment recommendation. 41 Upward migration could have a combination of causes:
suction from negative intracranial pressure created by CSF drainage, extrusion from the abdomen by positive intra-abdominal pressure (which occurs secondary to physiological processes), excessive CSF within the abdomen, convoluted SC tunneling as well as lack of correct fixation of the catheters. A "windlass effect" also has been described. A proximal anchoring point (eg, granulation tissue), facilitates flexionextension movements of the head, which is conducted to the peritoneal catheter, generating a proximal winching effect. 42 It is possible that because of an increased range of motion in the neck and thoracic region of the cat, a similar "windlass effect" was created.
| Study limitations
One weakness of our study is the low evidence level of case series and case reports. Therefore, the published information is incomplete and inconsistent with regard to clinical presentation and diagnostic imaging, which makes the information less valuable. The complications cannot be linked to the clinical presentation. Our study concentrated on complications that may arise through the disease and shunt placement in idiopathic and congenital hydrocephalus only. The clinical findings on initial presentation were inconsistently reported. To complete the clinical picture, the clinical findings are included in Tables 1-3 . It is also difficult to distinguish between shunt-related complications and disease progression. The data regarding diagnostic imaging is very sparse and therefore was not included in our results: only 6 MRI studies have been repeated: 3 showed a reduction of ventricle size (median 129 days after surgery; range, 60-208 days). 19, 23, 25, 26 One had a slit-like ventricle because of overshunting 2 months later on. 20 One had clinical improvement, but similar ventricular dilatation as before 8 months after surgery. 22 There is a need for a standardized diagnostic evaluation and follow-up of hydrocephalus patients regarding neurological examination and diagnostic imaging. Two studies had an overlap in time and location. 15, 17 The data collection in 1 study was between 2001 and 2009 and mainly at the University of Giessen, Germany. 15 The other study enrolled cases from 2001 to 2003 at the University of Giessen. 17 In 4 cases, the specification of the shunt type used was missing. Some overlap of cases cannot be excluded completely. 
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